China Digest: AIpark, Meipian, HaploX Biotechnology secure funding

Photo: Reuters

AIpark, a smart parking solution provider, has raised $15 million in the latest round led by US-China Green Fund. Meanwhile, editorial design and sharing app Meipian and genetic sequencing firm HaploX Biotechnology have closed their series A+ rounds.

AIpark secures $15m in series A

AIpark, a smart parking technology solution provider, has raised over RMB100 million ($15 million) in a Series A financing round led by US-China Green Fund with co-investment from Banyan China Capital.

AIpark will use the funding to strengthen its research and development and expand into overseas markets such as Hong Kong and Singapore, according to the company’s announcement.

“The first and foremost challenge facing the creation of green smart cities is traffic congestion, environmental degradation and high energy consumption,” said US-China Green Fund CEO Dr.Bo Bai. “AIpark is the world’s first company that has commercially applied fully intelligent image recognition technology to address the main challenges of urban development. The company has already taken several major Chinese cities and become an industry leader.”

US-China Green Fund is a private equity fund aiming to promote sustainable green development in China. The fund focuses on green energy, energy efficiency and environmental protection, green smart cities and villages.

Meipian gets $6.6m in series A+

Matrix Partners China has led a $6.6 million series A+ in Meipian, a Chinese social media tool for editorial design and sharing app.

Meipian, based in Nanjing and founded in 2015, has developed the app that allows users to beautify article layouts and share it with friends through social media including WeChat and Weibo.

It received RMB17 million ($2.5 million) in series A from ZhenFund in March last year to attract more users and support them to create original contents. It claimed last year it had over 12 million users on the platform.

HaploX Bio raises $32m series A+

Shenzhen-based genetic sequencing company HaploX Biotechnology has raised $32 million in series A+ round led by Youchoose Capital.

The participants in the round include SB China Venture Capital (SBCVC) and Kexin Capital.

The company has developed its sequencing technology, which is capable of detecting circulating tumor DNA for personalized cancer therapy.

Also read:

China Digest: Henlius, Huitongda, Mustliten, WM Motor, Chomp Cloud get funding

China Digest: Citybox, Jiaanpei, Rogrand, Zhulilaiye, Viamax get funding

 

 

Singapore Reporter/s

In Singapore, we are looking to double our reporting team by this year-end to comprehensively cover the fast-moving world of funded startups and VC, PE & M&A deals. We want reporters who can tell our readers what is really happening in these sectors and why it matters to markets, companies and consumers. The ability to write precisely and urgently is crucial for these roles. Ideal candidates must have to ability to work in a collaborative, dynamic, and fast-changing environment. We want our new hires to be digitally savvy and ready to experiment with new forms of storytelling. Most importantly, we are looking for hard-hitting reporters who work well in a team. Collaboration and collegiality are a must.

Following vacancies can be applied for (only in Singapore).

Following vacancies can be applied for (only in Singapore).   

  • A reporter to track companies/startups that have raised private capital, and have the potential to become unicorns. SEA currently has over 40 companies with a valuation of over $100 million and under $1 billion.
  • A reporter who can get behind the scenes and reveal how funding rounds are put together, or why they’ve failed to materialise. She/he in this role will largely focus on long-format stories. 
  • A journalist to track special situations funds, distressed debt and private credit (from the PE angle) across Asia.

Singapore Reporter/s

In Singapore, we are looking to double our reporting team by this year-end to comprehensively cover the fast-moving world of funded startups and VC, PE & M&A deals. We want reporters who can tell our readers what is really happening in these sectors and why it matters to markets, companies and consumers. The ability to write precisely and urgently is crucial for these roles. Ideal candidates must have to ability to work in a collaborative, dynamic, and fast-changing environment. We want our new hires to be digitally savvy and ready to experiment with new forms of storytelling. Most importantly, we are looking for hard-hitting reporters who work well in a team. Collaboration and collegiality are a must.

Following vacancies can be applied for (only in Singapore).

Following vacancies can be applied for (only in Singapore).   

  • A reporter to track companies/startups that have raised private capital, and have the potential to become unicorns. SEA currently has over 40 companies with a valuation of over $100 million and under $1 billion.
  • A reporter who can get behind the scenes and reveal how funding rounds are put together, or why they’ve failed to materialise. She/he in this role will largely focus on long-format stories. 
  • A journalist to track special situations funds, distressed debt and private credit (from the PE angle) across Asia.